Health Benefits of Fish vs Plant Protein

A Danish research team once looked at Inuit populations in Greenland eating diets soaked in marine fat and saw, seemingly, no heart disease. That single, loosely documented observation from the 1970s helped launch decades of research into fish oil and the heart. It also turned out not to hold up. Later work found similar rates of coronary heart disease and atherosclerosis in those populations compared with age-matched Danish and Canadian controls (09:20). The story is a useful warning for the rest of the episode: a plausible idea can slip into what nutrition scientist Dr. Alan Flanagan calls "nutrition lore" long before anyone tests it properly.

What follows in this episode of Sigma Nutrition Radio, hosted by Danny Lennon with Flanagan, is a slow, careful walk through what actually justifies the advice most countries give about fish. The UK's Scientific Advisory Committee on Nutrition recommends at least two portions a week, roughly 120 to 140 grams each, with one portion being an oily fish such as salmon, sardines, or mackerel (03:44). The US Academy of Nutrition and Dietetics lands in similar territory, and Australia recommends two to three 150-gram servings (05:14). Japan, unsurprisingly given its naturally high fish intake, skips a general quota and instead targets specific risks: a sodium cap tied to salted and pickled fish, and a strict 80-gram weekly limit on high-mercury fish like bluefin tuna and swordfish for pregnant women (06:17). The guidelines converge, but convergence is not proof. The real question the episode asks is where the two-servings figure actually comes from, and whether it deserves the confidence usually placed in it.

The clearest early answer comes from the Zutphen study, a Dutch cohort of 872 men followed for 20 years starting in 1960, published in the New England Journal of Medicine in 1985 (13:38). Average fish intake was about 20 grams a day, two-thirds of it lean fish like cod, one-third fatty fish like herring and mackerel. Men in the highest intake groups, above roughly 30 grams a day, had over 50 percent lower risk of dying from coronary heart disease than men who ate the least (14:50). Translated into weekly terms, that top-performing intake worked out to about one to two servings a week, which is exactly where the modern guidelines sit. The authors themselves concluded this was enough to justify a public health recommendation.

Observation is not causation, though, and the strongest piece of evidence in the whole episode is a genuine experiment. The 1989 Diet and Reinfarction Trial, known as DART, randomized heart attack survivors to receive or not receive advice on three separate things: total fat intake, fatty fish intake of at least two servings a week, and cereal fiber (16:03). Only the fish advice moved the needle. Over two years, the group advised to eat fatty fish had 29 percent lower mortality, and the effect was driven entirely by fewer deaths from ischemic heart disease (17:22). Neither the fat advice nor the fiber advice made a measurable difference, and fish's benefit held up regardless of which other advice a person also received. It is one of very few food-based, rather than supplement-based, randomized trials in this entire field, which is why it carries so much weight.

The follow-up trial, DART 2, tried to extend the finding by adding fish oil capsules into the mix and did not replicate it. It also flagged an early signal of harm, an increase in atrial fibrillation in the fish oil arm (18:08). From that point, Flanagan explains, the field's attention drifted from fish as a food toward omega-3 capsules as a supplement, a shift that has quietly muddied a lot of later evidence, since fish and fish oil are not the same exposure.

A more recent and much larger dataset adds useful texture rather than overturning the picture. A pooled analysis by Mohan and colleagues combined individual data from four international studies, roughly 191,500 participants across 58 countries (21:03). Among people without existing cardiovascular disease, higher fish intake showed no clear benefit. But among the nearly 52,000 participants who already had vascular disease, eating about two servings a week compared with almost none was tied to 16 percent lower risk of major cardiovascular events and 18 percent lower total mortality (23:35). Where the type of fish was recorded, in one of the four cohorts, it was specifically high-omega-3 oily fish that carried the benefit, with a 6 percent lower cardiovascular risk per five-gram daily increment, while non-oily fish showed no association at all. The takeaway is not that guidelines are wrong, but that the evidence is strongest for people who already have heart disease, and for oily fish specifically, not fish in general.

The comparison problem

Here the episode turns from what fish does to what fish replaces, which is where most of the public confusion lives. Modern nutrition epidemiology increasingly uses substitution models: statistically swap a fixed amount of one food or nutrient for another and see what happens to disease risk. A 2023 meta-analysis by Neuenschwander and colleagues modeled replacing 50 grams a day of fish with 7 grams of nuts or 12.5 grams of legumes, using data from 24 cohorts, and found no significant difference in coronary heart disease or all-cause mortality either way (28:07). No harm, no benefit, and only very low certainty behind even that.

Other studies using a different substitution method, swapping 3 percent of energy from animal protein for plant protein, reach different conclusions, and the reason why is the real payoff of this episode. A widely cited 2016 paper by Song and colleagues, drawn from Harvard's Nurses' Health Study and Health Professionals Follow-up Study, found that replacing 3 percent of energy from fish protein with plant protein was linked to 6 percent lower total mortality and 12 percent lower cardiovascular mortality (33:26). But a 2024 paper by Zheng and colleagues, using the same 3-percent substitution model in the Pan-European EPIC cohort of roughly 31,000 people across seven countries, found essentially nothing, no signal for total cardiovascular disease, heart disease, or stroke in either direction (37:50).

Flanagan's explanation is that the American cohorts start from a background diet that is heavier in animal protein and lighter in plant protein than the European cohort, so almost any modeled shift toward plants looks beneficial there, regardless of whether fish itself is the active ingredient.

"It's a mathematical abstraction that is often then having to be forced to fit your data." — Dr. Alan Flanagan [41:13]

Because the swap is a statistical construction, not something most participants actually do, the result is pulled toward whatever people who already eat more plants and less fish look like in that particular population. Run the same model in a population with a different starting diet, and the number changes or disappears, exactly what happened between the US and European cohorts.

What vegetarian cohorts actually show

The episode's final piece of evidence looks at populations that avoid fish, or meat, or both. In the 2019 EPIC Oxford study of just under 49,000 people, pescatarians (people who eat fish but not meat) had 13 percent lower risk of ischemic heart disease than meat eaters over 18 years of follow-up, while vegetarians had a larger 22 percent lower risk, with tighter confidence intervals (44:38). Neither group showed a significant difference in stroke risk. In the 2024 Adventist Health Study-2, a religiously and ethnically diverse US cohort of nearly 88,500 people, pesco-vegetarians had 15 percent lower all-cause mortality at age 65 compared with regular meat eaters, falling to a still-significant 10 percent at age 85 (47:59).

Put together, these cohorts show that multiple versions of a low-meat or no-meat diet, with or without fish, land in broadly similar, favorable territory. That is the evidence Flanagan leans on for the episode's central conclusion.

"Fish itself is not biologically necessary or is some type of indispensable food." — Danny Lennon [58:12]

Guidelines recommending two servings a week are not wrong, he argues, and they are not arbitrary either, they trace back to real cohort data and one solid trial. But they are not a floor beneath which health collapses. A person eating a well-planned, plant-forward diet with zero fish is not missing an essential ingredient, and a person who already eats fish twice a week is not obligated to cut it for a marginal, population-specific statistical gain. For anyone on a tight food budget, canned mackerel or sardines, at around 80 pence a tin, remain one of the cheapest ways to get omega-3s into a diet (59:54). For everyone else, the more useful move might be worrying less about fish and more about the sodium and fiber intake that most Western diets actually get wrong.